1Rood J I, Cole S T. Microbiol Rev, 1991, 55 (4) : 621 -648.
2Titball R W, Hunter S E C , Martin K L, et al. Infect Immun, 1989, 57 (2) : 367 -376.
3Henricus L Klaasen B M , Molkenboer J C H, et al. FEMS Immunology. and Medical Microbiology, 1999, 24:325 -332.
4Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning. 2nd Ed. New York: Cold Spring Harbor Laboratory Press,1989.
5Meacock P A, Cohen S N. Cell, 1980, 20 (2) : 529 -542.
6Nagahama M, Okagawa Y, Nakayama T, et al. J Bacteriol, 1995, 177 (5) : 1179 -1185.
7Guillouard I, Gamier T, Cole S T. Infect Immun, 1996, 64 (7) : 2440 -2444.
8Williamson E D, Titball R W. Vaccine, 1993, 11 (12) : 1253 - 1258.
9Rood J I, Cole S T. Molecular genetics and pathogenesis of Clostridium perfringens. Microbiol Rev, 1991,55(4) :621 - 648.
10Titball R W, Hunter S E C, Martin K L, et al. Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringens. Infect Immun, 1989,57(2) : 367 - 376.
